MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
241.31
+0.01
+0.00%
After Hours: 243.49 +2.18 +0.90% 19:54 04/09 EDT
OPEN
241.30
PREV CLOSE
241.30
HIGH
244.20
LOW
240.54
VOLUME
6.22M
TURNOVER
--
52 WEEK HIGH
251.71
52 WEEK LOW
137.66
MARKET CAP
581.22B
P/E (TTM)
21.87
1D
5D
1M
3M
1Y
5Y
1D
Is It Time To Reassess Johnson & Johnson (JNJ) After Its Strong 1-Year Share Price Run?
Simply Wall St · 48m ago
This Utility Could Be the Next Dividend Aristocrat. It May Return 10% This Year.
Barron‘s · 6h ago
Gear Up for Johnson & Johnson (JNJ) Q1 Earnings: Wall Street Estimates for Key Metrics
NASDAQ · 11h ago
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga · 12h ago
Barclays Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)
TipRanks · 15h ago
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity
Seeking Alpha · 1d ago
Johnson & Johnson Price Target Announced at $250.00/Share by TD Cowen
Dow Jones · 1d ago
TD Cowen Assumes Johnson & Johnson at Buy, Announces Price Target of $250
Benzinga · 1d ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.